Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.
Apex Science & Engineering (TPE:3052) Sloan Ratio % Explanation
A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.
If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.
If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.
If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.
As of Jun. 2026, Apex Science & Engineering has a Sloan Ratio of -12.67%, indicating there is a warning stage of accrual build up.
Apex Science & Engineering Sloan Ratio % Related Terms
Apex Science & Engineering Sloan Ratio % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:3052 vs PWR, FIX, EME: Sloan Ratio % Comparison
For the Engineering & Construction subindustry, Apex Science & Engineering's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Apex Science & Engineering Sloan Ratio % vs Construction Industry
For the Construction industry and Industrials sector, Apex Science & Engineering's Sloan Ratio % distribution charts can be found below:
* The bar in red indicates where Apex Science & Engineering's Sloan Ratio % falls into.
Apex Science & Engineering Sloan Ratio % Calculation
Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.
Apex Science & Engineering's Net Income for the trailing twelve months (TTM) ended in Jun. 2026 was 58.524 (Sep. 2025 ) + 29.689 (Dec. 2025 ) + 39.093 (Mar. 2026 ) + 100.688 (Jun. 2026 ) = NT$228 Mil.
Apex Science & Engineering's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was 1842.828 (Sep. 2025 ) + -401.653 (Dec. 2025 ) + 727.435 (Mar. 2026 ) + -421.618 (Jun. 2026 ) = NT$1,747 Mil.
Apex Science & Engineering's Cash Flow from Investing for the trailing twelve months (TTM) ended in Jun. 2026 was -10.371 (Sep. 2025 ) + -36.866 (Dec. 2025 ) + 3.291 (Mar. 2026 ) + 1.391 (Jun. 2026 ) = NT$-43 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apex Science & Engineering (TPE:3052) has a Sloan Ratio % of -12.67% as of Jun. 2026. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Apex Science & Engineering and its competitors.
Is Apex Science & Engineering's Sloan Ratio % too high?
Apex Science & Engineering's current Sloan Ratio % is -12.67%. Overall, Apex Science & Engineering has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Apex Science & Engineering's Sloan Ratio % compare to PWR and FIX?
Apex Science & Engineering's Sloan Ratio % of -12.67% can be compared against companies in the Construction industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Sloan Ratio % for a Construction company?
A good Sloan Ratio % depends on the Construction industry context. However, Sloan Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Sloan Ratio % mean?
A high Sloan Ratio % can signal that a stock is expensive relative to its fundamentals. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Apex Science & Engineering and its competitors. Apex Science & Engineering's current Sloan Ratio % is -12.67%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apex Science & Engineering stock overvalued right now?
Based on GuruFocus' analysis, Apex Science & Engineering (TPE:3052) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$12.64, compared to a current price of NT$11.25 — trading 11% below its estimated fair value. The current Sloan Ratio % is -12.67%. Apex Science & Engineering's overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Sloan Ratio % calculated?
Sloan Ratio % is calculated from a company's financial statements. For Apex Science & Engineering (TPE:3052), the current Sloan Ratio % is -12.67% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Apex Science & Engineering (TPE:3052) Overvalued in 2026?
Based on GuruFocus' analysis, Apex Science & Engineering stock appears to be undervalued.
The current stock price of NT$11.25 is trading 11% below its estimated GF Value™ of NT$12.64.
GuruFocus considers Apex Science & Engineering to be Modestly Undervalued.
Key valuation signals for TPE:3052:
Sloan Ratio %: -12.67%
GF Value™: NT$12.64 vs. price of NT$11.25 (11% below fair value)
No single metric tells the full story. See the TPE:3052 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Apex Science & Engineering Corp, and its subsidiaries, work on projects in mechanical engineering, instrument engineering, environment engineering, related electrical products manufacturing and sales, entrusted construction of factories, residential and commercial buildings, as well as development of special zones, etc.
73GF Score
Get the complete analysis for TPE:3052
Sloan Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:3052 has been successfully added to your 
